Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PLX PHARMA INC.

(PLXP)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

PLx Pharma Shares Up 30% as Vazalore Set To Launch in Walmart in August

07/13/2021 | 01:31pm EDT

By Michael Dabaie

PLx Pharma Inc. shares were up 30% to $16.10 in Tuesday afternoon trading after the specialty pharmaceutical company said its Vazalore is set to launch in Walmart stores in August.

PLx said three stock-keeping units of Vazalore U.S. Food and Drug Administration approved liquid-filled aspirin capsules will be available in more than 4,500 Walmart stores across the U.S. in mid-August.

Walmart has already inserted placeholders to reserve space on shelves and alert customers that Vazalore is coming soon, PLx said.

"The company has indicated it anticipates agreements with all the major U.S. drug store retailers ahead of launch in 3Q21 but obviously the Walmart agreement is significant in that is the first disclosed as well as representing first major external endorsement and thus validation of VAZALORE's commercial potential," Raymond James said in a note.

"Gearing up for the nationwide launch, Walmart is the first major retailer to dedicate shelf space to the newly FDA-approved product. The shelf placeholders not only reserve shelf space for VAZALORE, but also begin the process of alerting customers about the innovative aspirin product," Raymond James said.

Write to Michael Dabaie at michael.dabaie@wsj.com

(END) Dow Jones Newswires

07-13-21 1531ET

Stocks mentioned in the article
ChangeLast1st jan.
PLX PHARMA INC. -1.19% 17.39 Delayed Quote.215.04%
WALMART INC. -0.21% 144.73 Delayed Quote.0.40%
All news about PLX PHARMA INC.
09/09PLX PHARMA : to Present at Upcoming Virtual Healthcare Industry Conferences
AQ
08/26PLX PHARMA : Announces Nationwide Rollout of Aspirin Capsules
MT
08/26PLX PHARMA : VAZALORE™ Now on Shelves; National Media Campaign Launches To..
AQ
08/06PLX PHARMA INC. : Entry into a Material Definitive Agreement, Financial Statemen..
AQ
08/06PLX PHARMA : Q2 Loss Widens
MT
08/06PLX PHARMA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RES..
AQ
08/06Plx Pharma Inc. Reports Earnings Results for the Second Quarter Ended June 30..
CI
08/06PLX PHARMA INC. : Results of Operations and Financial Condition, Financial State..
AQ
08/06PLX PHARMA : Reports Second Quarter 2021 Results and Provides Business Update
AQ
08/03PLX PHARMA : to Launch Vazalore in 8,000 CVS Stores in August
MT
More news
Analyst Recommendations on PLX PHARMA INC.
More recommendations
Financials (USD)
Sales 2021 9,97 M - -
Net income 2021 -45,2 M - -
Net Debt 2021 - - -
P/E ratio 2021 -8,41x
Yield 2021 -
Capitalization 468 M 468 M -
Capi. / Sales 2021 46,9x
Capi. / Sales 2022 15,2x
Nbr of Employees 10
Free-Float 89,5%
Chart PLX PHARMA INC.
Duration : Period :
PLx Pharma Inc. Technical Analysis Chart | PLXP | US72942A1079 | MarketScreener
Technical analysis trends PLX PHARMA INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 3
Last Close Price 17,39 $
Average target price 21,50 $
Spread / Average Target 23,6%
EPS Revisions
Managers and Directors
Natasha Giordano President, Chief Executive Officer & Director
Rita M. O'Connor CFO, Head-Manufacturing & Supply Chain
Michael J. Valentino Executive Chairman
Gary S. Balkema Independent Director
Kirk K. Calhoun Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PLX PHARMA INC.215.04%468
GILEAD SCIENCES, INC.22.91%89 785
BIONTECH SE340.60%86 750
WUXI APPTEC CO., LTD.35.75%69 350
REGENERON PHARMACEUTICALS34.93%67 775
VERTEX PHARMACEUTICALS-20.33%48 850